Y-mAbs Therapeutics Inc (NASDAQ:YMAB)

4.41
BATS BZX Real-Time Price
As of 10:17am ET
 -0.04 / -0.90%
Today’s Change
2.94
Today|||52-Week Range
20.48
-9.73%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$193.9M

Company Description

Y-mAbs Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of antibody based therapeutic products for the treatment of cancer. Its services include discovery, protein engineering, clinical and regulatory. Y-mAbs Therapeutics was founded by Thomas Gad in April 2015 and is headquartered in New York, NY.

Contact Information

Y-mAbs Therapeutics, Inc.
230 Park Avenue
New York New York 10169-0005
P:(646) 885-8505
Investor Relations:

Employees

Shareholders

Mutual fund holders32.75%
Other institutional24.73%
Individual stakeholders22.11%

Top Executives

Thomas GadPresident, Chief Executive Officer & Director
Joris Wiel Jan WilmsChief Operating Officer & Senior Vice President
Bo KruseCFO, Secretary. Treasurer & Executive VP
Torben Lund-HansenChief Technology Officer & Senior Vice President
Steen LisbyChief Scientific Officer & Senior Vice President